Wayne has almost 30 years’ experience in synthetic and medicinal chemistry both in academia, government and industry
Robert has 30 years’ experience in corporate finance and equity.
Previously at Wellcome Research Laboratories, Peptech and Cambridge Antibody Technology.
Also QinetiQ, pSivida, Clinuvel, HalcyGen and Ascent Pharma Health. More recently CEO of Mayne Pharma Group.
The principal activities of the company are to develop its own drug discovery intellectual property, namely three platforms for the treatment of different types of cancers in humans and animals, as well as providing highly specialised medicinal and synthetic chemistry services on a contract basis to clients.
Chief Executive Officer
Dr Hopkins is an experienced pharmaceutical executive with over 10 years in corporate leadership roles.
Pharmaust © 2013 | All Rights Reserved Online Marketing & Website Design By Total Click Solutions
©2013 PharmAust Limited (ABN 35 094 006 023)
Tel: +61 8 6364 0899 | Fax: +61 8 9467 6111